Following the PCMCH’s release of its recommendation and Guideline for the Use of Fetal Fibronectin (fFN) testing in Ontario, with the support of the Ministry of Health and Long-Term Care, fFn testing was adopted province-wide.
fFN testing assists clinicians in determining whether a woman, who may be at risk of preterm birth, requires admission to hospital and/or transfer to a high risk perinatal unit. Evaluation of the testing protocol revealed significant cost savings to health provider organizations and the system as a whole, as well as increased quality and safety of care to mothers and their newborns.
The following resources serve to augment the education provided by Hologic, and to provide 24/7 access to information for healthcare providers in Ontario hospitals.
Fetal Fibronectin – Patient Handout
A patient handout on Fetal Fibronectin testing.
Fetal Fibronectin Utilization Tracking Tool Guidelines
A Fetal Fibronectin Utilization Tracking Tool Guidelines.
Fetal Fibronectin – Policy and Procedure
A generic Policy and Procedure that hospitals can use as a template for developing a hospital specific policy and procedure.
Fetal Fibronectin – Pre-Test and Post-Test
A pre-test and post test that can be used by hospital staff to test their knowledge prior to and after education on fetal fibronectin testing.
Guideline for Fetal Fibronectin Testing
The Ministry of Health Guideline for Fetal Fibronectin Testing.